Pre-Seed Venture Capital

Mechanism

At pre-seed, investors cannot judge a business by revenue because there is none. They judge four things: the founders' ability to execute, the size and urgency of the problem, early signals from customers and the plan for the money. Pre-seed rounds are small, informal and mostly built on convertible instruments such as SAFEs and notes, since pricing a company with no operating history is arbitrary. The mechanics of those instruments are covered in seed funding rounds.

Four sources of capital meet at this stage.

• Angels: individuals investing their own money, usually in small checks.
• Accelerators: programs that invest a standard amount for a fixed share and offer mentoring.
• Pre-seed funds: venture funds that specialize in first checks and hold ownership targets across many companies.
• Scouts and operators: individuals backed by a larger firm to find early companies.

Whichever source is used, the central planning formula is runway: cash divided by monthly net burn. The round should fund a milestone, not merely a number of months, and should leave a cushion for the next fundraising process.

Worked Example

Consider a hypothetical three-founder software company planning a pre-seed round. Monthly spending is shown below.

The company wants to reach ten paying pilot customers in 12 months, then spend six months on a seed round. That is 18 months of burn, or $810,000. A $750,000 round would last only 16.7 months, about 1.3 months short of the plan, so the founders either raise $810,000 or cut burn to $41,667 a month. If they sell $810,000 of SAFEs with a $7,500,000 post-money valuation cap, investors hold $810,000 divided by $7,500,000, or 10.8 percent, immediately before the next priced round. Sizing a round from a milestone plan gives investors a reason for the amount and keeps founders from selling more than they need.

Pre-Seed Venture Capital: What Investors Look For

Investors in this stage usually test for founder-market fit: why this team, with this experience, will solve this problem better than others. They look for evidence of customer demand, even if informal: interviews, waitlists, letters of intent, pilot agreements or a prototype in use. They ask how the team will use the money, what the next milestone is and who else will fund the following round. Terms matter less than relationships, but founders should still read every document and track every SAFE signed, since each one dilutes the founders at conversion.

Securities law applies even to small rounds. Most pre-seed rounds are sold to accredited investors under Regulation D, where an individual generally qualifies with a net worth above $1,000,000, alone or jointly with a spouse or spousal equivalent and excluding a primary residence, or with income above $200,000 in each of the two most recent years, or $300,000 jointly, and a reasonable expectation of the same in the current year (17 CFR 230.501). A company that relies on Rule 506(b) cannot advertise the round publicly, and it files a Form D within 15 calendar days after the first sale (17 CFR 230.503).

What It Means for a Limited Partner

A pre-seed strategy is a high-volume, high-loss approach. Checks are small and many companies fail, so results depend on a few outcomes and on how much ownership the manager keeps in them. A limited partner should ask how many companies the partnership expects to back, what percentage ownership it targets at entry, how it reserves for later rounds and how it values SAFEs before they convert. Management fees weigh more heavily on small funds because a fixed cost of running a firm takes a larger share of a smaller pool; the effect is quantified in Management Fee. Reported value also moves little until a priced round occurs, so interim performance tells an investor little, and the J-Curve can last longer than in later-stage strategies. The differences between the two main sources of early capital are set out in venture capital vs angel investors.

In Life Sciences and Healthcare

Pre-seed in life sciences often means funding a founder-scientist through license negotiation, proof-of-concept experiments and a first conversation with the regulator. Capital needs are higher than software because laboratory work, animal studies and regulatory consultants cost more. Investors look at the quality of the underlying science, the freedom to operate and the team's access to clinical or commercial expertise, and they plan milestones around data rather than product launches. A pre-seed investor in this field should also ask how the company will fund the gap between laboratory results and the first financing large enough to start clinical work.

Frequently Asked Questions

What is pre-seed funding?

Pre-seed funding is the first outside money a startup takes, usually before it has paying customers. It pays for prototypes, customer discovery and early hires, and it typically comes from angels, accelerators and specialist funds through SAFEs or convertible notes rather than a priced round.

How much should a company raise at pre-seed?

Raise enough to reach a specific milestone and to run the next fundraising process. A useful formula is monthly net burn multiplied by months to milestone plus months of fundraising. In the example above, $45,000 times 18 months equals $810,000. Round up for surprises but do not sell more of the company than the plan needs.

Do pre-seed investors expect revenue?

Not usually. They look for evidence that the problem is real and that the team can build a solution: customer interviews, pilots, waitlists or a working prototype. Revenue helps, but the most valuable evidence at this stage is repeated proof that specific buyers have the problem and would pay to solve it. See early-stage venture capital.

Related Reference

The earliest capital leads, if a company succeeds, to the later stages of growth equity. Related entries: Startup Funding Stages, Seed Funding Rounds and The J-Curve.